SUVEN PHARMACEUTICALS
Back to Income Statement
|
SUVEN PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹300 Cr | ₹41,129 Cr | ₹454 Cr | ₹362 Cr | ₹317 Cr |
What is the latest Consolidated Net Profit of SUVEN PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹300 Cr |
| Mar2024 | ₹41,129 Cr |
| Mar2023 | ₹454 Cr |
| Mar2022 | ₹362 Cr |
| Mar2021 | ₹317 Cr |
How is Consolidated Net Profit of SUVEN PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹300 Cr | -99.27 | |
| Mar2024 | ₹41,129 Cr | 8,963.15 | |
| Mar2023 | ₹454 Cr | 25.24 | |
| Mar2022 | ₹362 Cr | 14.30 | |
| Mar2021 | ₹317 Cr | - | |
Compare Consolidated Net Profit of peers of SUVEN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN PHARMACEUTICALS | ₹13,526.8 Cr | -3.6% | -25.6% | -69.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹409,698.0 Cr | 0.2% | -1.3% | -3.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,866.0 Cr | 1.9% | -6.7% | 0.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,062.0 Cr | 1.3% | 2.9% | 28.7% | Stock Analytics | |
| CIPLA | ₹108,412.0 Cr | 1.3% | -8.5% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,805.0 Cr | 1.3% | 3.8% | 4.5% | Stock Analytics | |
SUVEN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN PHARMACEUTICALS | -3.6% |
-25.6% |
-69.3% |
| SENSEX | 0.6% |
0.1% |
9.2% |
You may also like the below Video Courses